We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis (Cancer-DACUS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00450645
Recruitment Status : Unknown
Verified March 2009 by Azienda Ospedaliera Universitaria Policlinico.
Recruitment status was:  Recruiting
First Posted : March 22, 2007
Last Update Posted : March 4, 2009
Sponsor:
Information provided by: